A comprehensive review of the therapeutic potential of curcumin nanoformulations

K Khezri, M Saeedi, H Mohammadamini… - Phytotherapy …, 2021 - Wiley Online Library
Today, due to the prevalence of various diseases such as the novel coronavirus (SARS‐
CoV‐2), diabetes, central nervous system diseases, cancer, cardiovascular disorders, and …

[HTML][HTML] Therapeutic applications of curcumin nanoformulations

MM Yallapu, PKB Nagesh, M Jaggi, SC Chauhan - The AAPS journal, 2015 - Springer
Curcumin (diferuloylmethane) is a bioactive and major phenolic component of turmeric
derived from the rhizomes of curcuma longa linn. For centuries, curcumin has exhibited …

[HTML][HTML] Nanocurcumin: A promising candidate for therapeutic applications

A Karthikeyan, N Senthil, T Min - Frontiers in Pharmacology, 2020 - frontiersin.org
Curcuma longa is an important medicinal plant and a spice in Asia. Curcumin
(diferuloylmethane) is a hydrophobic bioactive ingredient found in a rhizome of the C. longa …

Effect of nano‐curcumin on various diseases: a comprehensive review of clinical trials

S Hassanizadeh, M Shojaei, M Bagherniya… - Biofactors, 2023 - Wiley Online Library
The antioxidant, anti‐inflammatory, and antibacterial properties of curcumin have made it a
valuable herbal product for improving various disorders, such as COVID‐19, cancer …

[HTML][HTML] Prospects of curcumin nanoformulations in cancer management

H Amekyeh, E Alkhader, R Sabra, N Billa - Molecules, 2022 - mdpi.com
There is increasing interest in the use of natural compounds with beneficial pharmacological
effects for managing diseases. Curcumin (CUR) is a phytochemical that is reportedly …

Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives

P Sivasami, T Hemalatha - Artificial Cells, Nanomedicine, and …, 2018 - Taylor & Francis
Curcumin, an active principle of Curcuma longa, is extracted from the rhizome. Its
therapeutic efficiency has been proved using various in vitro and in vivo models …

Advances in curcumin-loaded nanopreparations: Improving bioavailability and overcoming inherent drawbacks

Y Zhang, A Rauf Khan, M Fu, Y Zhai, J Ji… - Journal of Drug …, 2019 - Taylor & Francis
Curcumin (CUR), one of the major extracts of turmeric, has gained extensive attention owing
to its extraordinary benefits as anti-cancer, anti-bacterial, anti-ulcerative, anti-depressant …

[HTML][HTML] The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders

P Tagde, P Tagde, F Islam, S Tagde, M Shah… - Molecules, 2021 - mdpi.com
Curcumin is the primary polyphenol in turmeric's curcuminoid class. It has a wide range of
therapeutic applications, such as anti-inflammatory, antioxidant, antidiabetic …

An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline?

F Olotu, C Agoni, O Soremekun… - Cell Biochemistry and …, 2020 - Springer
The pharmacological propensities of curcumin have been reported in a plethora of pre-
clinical and clinical studies. However, innate attributes account for extremely low oral …

Curcumin as potential therapeutic natural product: a nanobiotechnological perspective

S Shome, AD Talukdar, MD Choudhury… - Journal of Pharmacy …, 2016 - academic.oup.com
Objectives Nanotechnology-based drug delivery systems can resolve the poor
bioavailability issue allied with curcumin. The therapeutic potential of curcumin can be …